New hope for advanced cervical cancer: drug combo aims to extend survival
Disease control
Not yet recruiting
This study tests whether a new combination of two drugs (WX390 and toripalimab) can help people with advanced cervical cancer that has come back or spread and no longer responds to standard platinum chemotherapy. About 440 adults aged 18 to 75 will be randomly assigned to receive…
Phase: PHASE3 • Sponsor: Shanghai Jiatan Pharmatech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 15:41 UTC